H. Baumgartner, V. Falk, and J. J. Bax, ESC/ EACTS guidelines for the management of valvular heart disease, Eur Heart J, vol.38, pp.2739-91, 2017.

M. J. Mack, M. B. Leon, and C. R. Smith, 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PART-NER 1): a randomised controlled trial, Lancet, vol.385, pp.2477-84, 2015.

V. H. Thourani, S. Kodali, and R. R. Makkar, Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis, Lancet, vol.387, pp.2218-2243, 2016.

P. F. Ludman, N. Moat, and M. A. De-belder, Transcatheter aortic valve implantation in the United Kingdom: temporal trends, predictors of outcome, and 6-year follow-up: a report from the UK Transcatheter Aortic Valve Implantation (TAVI) Registry, Circulation, vol.131, pp.1181-90, 2007.

V. Auffret, T. Lefevre, and E. Van-belle, Temporal trends in transcatheter aortic valve replacement in France: FRANCE 2 to FRANCE TAVI, J Am Coll Cardiol, vol.70, pp.42-55, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01744757

J. S. Patel, A. Krishnaswamy, L. G. Svensson, E. M. Tuzcu, S. Mick et al., Access options for transcatheter aortic valve replacement in patients with unfavorable aortoiliofemoral anatomy, Curr Cardiol Rep, vol.18, p.110, 2016.

R. A. Nishimura, C. M. Otto, and R. O. Bonow, , 2017.

. Aha/acc, AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, J Am Coll Cardiol, vol.70, pp.252-89, 2014.

T. Folliguet, N. Laurent, and M. Bertram, Transcarotid transcatheter aortic valve implantation: multicentre experience in France, Eur J Cardiothorac Surg, vol.53, pp.157-61, 2018.

A. Rojas, P. Gutiérrez, and H. , Transubclavian approach: a competitive access for transcatheter aortic valve implantation as compared to transfemoral, Catheter Cardiovasc Interv, vol.92, pp.935-979, 2018.

T. Modine, A. Sudre, and C. Delhaye, Transcutaneous aortic valve implantation using the left carotid access: feasibility and early clinical outcomes, Ann Thorac Surg, vol.93, pp.1489-94, 2012.

T. Modine, G. Lemesle, R. Azzaoui, and A. Sudre, Aortic valve implantation with the CoreValve ReValving System via left carotid artery access: first case report, J Thorac Cardiovasc Surg, vol.140, pp.928-937, 2010.

E. H. Blackstone, R. M. Suri, and J. Rajeswaran, Propensity-matched comparisons of clinical outcomes after transapical or transfemoral transcatheter aortic valve replacement: a placement of aortic transcatheter valves (PARTNER)-I trial substudy, Circulation, vol.131, pp.1989-2000, 2015.

T. Chollet, B. Marcheix, and N. Boudou, Propensity-matched comparison of clinical outcomes after transaortic versus transfemoral aortic valve replacement, EuroIntervention, vol.14, pp.750-757, 2018.

A. P. Kappetein, S. J. Head, and P. Généreux, Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document, Eur Heart J, vol.33, pp.2403-2421, 2012.

M. Erlebach, S. J. Head, and D. Mylotte, VARC endpoint definition compliance rates in contemporary transcatheter aortic valve implantation studies, EuroIntervention, vol.12, pp.375-80, 2016.

J. P. Vandenbroucke, The making of STROBE, Epidemiology, vol.18, pp.797-806, 2007.

J. J. Popma, G. M. Deeb, and S. J. Yakubov,

, Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients, N Engl J Med, vol.380, pp.1706-1721, 2019.

C. Chamandi, R. Abi-akar, and J. Rodés-cabau, Transcarotid compared with other alternative access routes for transcatheter aortic valve replacement, Circ Cardiovasc Interv, vol.11, p.6388, 2018.

O. Husser, B. Fujita, and C. Hengstenberg, Conscious sedation versus general anesthesia in transcatheter aortic valve replacement: the German Aortic Valve Registry, J Am Coll Cardiol Intv, vol.11, pp.567-78, 2018.

M. Droppa, O. Borst, and T. Katzenberger, Comparison of safety and periprocedural complications of transfemoral aortic valve replacement in local anesthesia in minimalist versus complete heart team, EuroIntervention, vol.14, pp.1819-1844, 2019.

P. Généreux, J. G. Webb, and L. G. Svensson, Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial, J Am Coll Cardiol, vol.60, pp.1043-52, 2012.

J. Rodés-cabau, E. Dumont, and R. H. Boone, Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches, J Am Coll Cardiol, vol.57, pp.18-28, 2011.

M. Pagnesi, E. A. Martino, and M. Chiarito, Silent cerebral injury after transcatheter aortic valve implantation and the preventive role of embolic protection devices: a systematic review and metaanalysis, Int J Cardiol, vol.221, pp.97-106, 2016.

D. Jochheim, M. Zadrozny, and R. I. , Predictors of cerebrovascular events at mid-term after transcatheter aortic valve implantationresults from EVERY-TAVI registry, Int J Cardiol, vol.244, pp.106-117, 2017.

A. J. Lansky, J. Schofer, and D. Tchetche, A prospective randomized evaluation of the Tri-Guard TM HDH embolic DEFLECTion device during transcatheter aortic valve implantation: results from the DEFLECT III trial, Eur Heart J, vol.36, pp.2070-2078, 2015.